Shopping Cart
- Remove All
- Your shopping cart is currently empty
LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
10 mg | Inquiry | 10-14 weeks | |
50 mg | Inquiry | 10-14 weeks |
Description | LW-216 is a TrxR1 inhibitor that induces cell apoptosis (Apoptosis) and possesses antitumor activity. |
In vitro | LW-216 (5-25 μM, 24 h) selectively decreases the TrxR1 protein levels in NCI-H460 and A549 cells, subsequently inducing apoptosis. |
In vivo | LW-216 administered intravenously (8 mg/kg, once every two days for 18 days) effectively suppressed tumor growth in a xenograft mouse model employing NCI-H460 cells. This treatment regimen significantly reduced bioluminescence intensity and increased the levels of apoptosis-inducing proteins Bax and Cleaved Caspase-3. Concurrently, there was a noticeable reduction in the expression of the proliferation marker Ki67. |
Molecular Weight | 485.57 |
Formula | C30H31NO5 |
Cas No. | 2146090-18-6 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.